Diluting With Cerebrospinal Fluid Versus Traditional Intrathecal Administration: Antishivering Effects
NCT02189655
·
clinicaltrials.gov ↗
NA
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Conditions
Antishivering Effects
Interventions
PROCEDURE:
bupivacaine 0.5% 2.5 mL diluting with cerebrospinal fluid
Sponsor
China Medical University, China